|
|
Volumn 44, Issue 5, 2014, Pages 475-476
|
|
Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CIPROFLOXACIN;
COLISTIN;
IMIPENEM;
POLYMYXIN B;
RIFAMPICIN;
TETRACYCLINE;
ANTIINFECTIVE AGENT;
ACINETOBACTER BAUMANNII;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL GROWTH;
BACTERIAL MUTATION;
BACTERIAL STRAIN;
BACTERIUM ISOLATE;
CONCENTRATION (PARAMETERS);
DRUG POTENTIATION;
GRAM NEGATIVE BACTERIUM;
HOSPITAL INFECTION;
KLEBSIELLA PNEUMONIAE;
LETTER;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANCE;
MUTANT PREVENTION CONCENTRATION;
NONHUMAN;
PSEUDOMONAS AERUGINOSA;
ACINETOBACTER INFECTION;
DRUG EFFECTS;
DRUG INTERACTION;
GENETICS;
HUMAN;
ISOLATION AND PURIFICATION;
KLEBSIELLA INFECTION;
MICROBIAL SENSITIVITY TEST;
MICROBIOLOGY;
MUTATION;
PSEUDOMONAS INFECTION;
ACINETOBACTER BAUMANNII;
ACINETOBACTER INFECTIONS;
ANTI-INFECTIVE AGENTS;
COLISTIN;
DRUG INTERACTIONS;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
KLEBSIELLA INFECTIONS;
KLEBSIELLA PNEUMONIAE;
MICROBIAL SENSITIVITY TESTS;
MUTATION;
PSEUDOMONAS AERUGINOSA;
PSEUDOMONAS INFECTIONS;
|
|
EID: 84908450703
PISSN: 09248579
EISSN: 18727913
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2014.07.015 Document Type: Letter |
|
Times cited : (6)
|
|
References (5)
|
